Rapid induction of skin tumors in human but not mouse c-Ha-ras proto-oncogene transgenic mice by chemical carcinogenesis

Cancer Science

Volumn 97, Issue 9, 2006, Pages 842-847

  Muto, Satoru ^a   Katsuki, Motoya ^b   Horie, Shigeo ^a  

^a TEIKYO UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE FOR BASIC BIOLOGY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DIMETHYLBENZ[A]ANTHRACENE; ONCOPROTEIN; PROTEIN C H RAS; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CODON; CONTROLLED STUDY; FEMALE; MALE; MOUSE; MUTATIONAL ANALYSIS; NONHUMAN; NUCLEIC ACID BASE SUBSTITUTION; ONCOGENE C H RAS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SENSITIVITY ANALYSIS; SKIN TUMOR; TISSUE DISTRIBUTION; TISSUE SPECIFICITY; TRANSGENIC MOUSE; TUMOR VOLUME; WESTERN BLOTTING; WILD TYPE;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; BASE SEQUENCE; BLOTTING, WESTERN; CARCINOGENS; DNA MUTATIONAL ANALYSIS; GENES, RAS; HUMANS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEOPLASMS, SQUAMOUS CELL; ONCOGENE PROTEIN P21(RAS); POINT MUTATION; POLYMERASE CHAIN REACTION; PROMOTER REGIONS (GENETICS); PYRIDINES; SKIN NEOPLASMS; SPECIES SPECIFICITY;

EID: 33746605094     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2006.00256.x     Document Type: Article

References (39)

1. Hahn WC, Weinberg RA. Modeling the molecular circuitry of cancer. Nat Rev Cancer 2002; 2: 331-41.
2. Weinberg RA. Oncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis. Cancer Res 1989; 49: 3713-21.
3. DiGiovanni J. Multistage carcinogenesis in mouse skin. Pharmacol Ther 1992; 54: 63-128.
4. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100: 57-70.
5. Bos JL. Ras oncogenes in human cancer: A review. Cancer Res 1989; 49: 4682-9.
6. Lowy DR, Willumsen BM. Function and regulation of ras. Annu Rev Biochem 1993; 62: 851-91.
7. Tomisawa M, Suemizu H, Ohnishi Y et al. Mutation analysis of vinyl carbamate or urethane induced lung tumors in rasH2 transgenic mice. Toxicol Lett 2003; 142: 111-7.
8. Suzuki R, Kohno H, Suzui M et al. An animal model for the rapid induction of tongue neoplasms in human c-Ha-ras proto-oncogene transgenic rats by 4-nitroquinoline 1-oxide: Its potential use for preclinical chemoprevention studies. Carcinogenesis 2006; 27: 619-30.
9. Saitoh A, Kimura M, Takahashi R et al. Most tumors in transgenic mice with human c-Ha-ras gene contained somatically activated transgenes. Oncogene 1990; 5: 1195-200.
10. Morton D, Alden CL, Roth AJ, Usui T. The Tg rasH2 mouse in cancer hazard identification. Toxicol Pathol 2002; 30: 139-46.
11. Tsuda H, Fukamachi K, Ohshima Y et al. High susceptibility of human c-Ha-ras proto-oncogene transgenic rats to carcinogenesis: A cancer-prone animal model. Cancer Sci 2005; 96: 309-16.
12. Okamura M, Moto M, Kashida Y, Machida N, Mitsumori K. Carcinogenic susceptibility to N-bis(2-hydroxypropyl)nitrosamine (DHPN) in rasH2 mice. Toxicol Pathol 2004; 32: 474-81.
13. Imaoka M, Kashida Y, Watanabe T et al. Tumor promoting effect of phenolphthalein on development of lung tumors induced by N-ethyl-N-nitrosourea in transgenic mice carrying human prototype c-Ha-ras gene. J Vet Med Sci 2002; 64: 489-93.
14. Maronpot MM, Mitsumori K, Mann P et al. Interlaboratory comparison of the CB6F1-Tg rasH2 rapid carcinogenicity testing model. Toxicology 2000; 146: 149-59.
15. Yamamoto S, Hayashi Y, Mitsumori K, Nomura T. Rapid carcinogenicity testing system with transgenic mice harboring human prototype c-HRAS gene. Lab Anim Sci 1997; 47: 121-6.
16. Gulezian D, Jacobson-Kram D, McCullough CB et al. Use of transgenic animals for carcinogenicity testing: Considerations and implications for risk assessment. Toxicol Pathol 2000; 28: 482-99.
17. Storer RD. Current status and use of short/medium term models for carcinogenicity testing of pharmaceuticals - scientific perspective. Toxicol Lett 2000; 112-113: 557-66.
18. Storer RD, French JE, Donehower LA et al. Transgenic tumor models for carcinogen identification: The heterozygous Trp53-deficient and RasH2 mouse lines. Mutat Res 2003; 540: 165-76.
19. Toyosawa K, Tanaka K, Imai T et al. Mutation and overexpression of the transgene in ethylnitrosourea-induced tumors in mice carrying a human prototype c-Ha-ras gene. Toxicol Pathol 2003; 31: 491-5.
20. Mitsumori K, Koizumi H, Nomura T, Yamamoto S. Pathological features of spontaneous and induced tumors in transgenic mice carrying a human prototype c-Ha-ras gene used for six-month carcinogenicity studies. Toxicol Pathol 1998; 26: 520-31.
21. Hayashi S, Mori I, Nonoyama T, Mitsumori K. Point mutations of the c-H-ras gene in spontaneous liver tumors of transgenic mice carrying the human c-H-ras gene. Toxicol Pathol 1998; 26: 556-61.
22. Watanabe T, Kashida Y, Yasuhara K, Koujitani K, Hirose M, Mitsumori K. Rapid induction of uterine endometrial proliferative lesions in transgenic mice carrying a human prototype c-Ha-ras gene (rasH2 mice) given a single intraperitoneal injection of N-ethyl-N-nitrosourea. Cancer Lett 2002; 188: 39-46.
23. Watanabe T, Kashida Y, Ueda M et al. Inhibition by ethinylestradiol of N-ethyl-N-nitrosourea-initiated uterine carcinogenesis in transgenic mice carrying a human prototype C-Ha-ras gene (rasH2 mice). Toxicol Pathol 2003; 31: 496-505.
24. Maruyama C, Tomisawa M, Wakana S et al. Overexpression of human H-ras transgene is responsible for tumors induced by chemical carcinogens in mice. Oncol Rep 2001; 8: 233-7.
25. Suemizu H, Muguruma K, Maruyama C et al. Transgene stability and features of rasH2 mice as an animal model for short-term carcinogenicity testing. Mol Carcinog 2002; 34: 1-9.
26. Asamoto M, Ochiya T, Toriyama-Baba H et al. Transgenic rats carrying human c-Ha-ras proto-oncogenes are highly susceptible to N-methyl-N-nitrosourea mammary carcinogenesis. Carcinogenesis 2000; 21: 243-9.
27. Han BS, Fukamachi K, Takasuka N et al. Inhibitory effects of 17beta-estradiol and 4-n-octylphenol on 7,12-dimethylbenz[a]anthracene-induced mammary tumor development in human c-Ha-ras proto-oncogene transgenic rats. Carcinogenesis 2002; 23: 1209-15.
28. Park CB, Fukamachi K, Takasuka C et al. Rapid induction of skin and mammary tumors in human c-Ha-ras proto-oncogene transgenic rats by treatment with 7,12-dimethylbenz[a]anthracene followed by 12-O-tetradecanoylphorbol 13-acetate. Cancer Sci 2004; 95: 205-10.
29. Ando K, Saitoh A, Hino O, Takahashi R, Kimura M, Katsuki M. Chemically induced forestomach papillomas in transgenic mice carry mutant human c-Ha-ras transgenes. Cancer Res 1992; 52: 978-82.
30. Yamamoto S, Mitsumori K, Kodama Y et al. Rapid induction of more malignant tumors by various genotoxic carcinogens in transgenic mice harboring a human prototype c-Ha-ras gene than in control non-transgenic mice. Carcinogenesis 1996; 17: 2455-61.
31. Mitsumori K, Wakana S, Yamamoto S et al. Susceptibility of transgenic mice carrying human prototype c-Ha-ras gene in a short-term carcinogenicity study of vinyl carbamate and ras gene analyses of the induced tumors. Mol Carcinog 1997; 20: 298-307.
32. Mori I, Yasuhara K, Hayashi S, Nonoyama T, Nomura T, Mitsumori K. Carcinogen dose-dependent variation in the transgene mutation spectrum in urethane-induced lung tumors in transgenic mice carrying the human prototype c-Ha-ras gene. Cancer Lett 2000; 153: 199-209.
33. Mitsumori K. Possible mechanism on enhanced carcinogenesis of genotoxic carcinogens and unsolved mechanisms on lesser carcinogenic susceptibility to some carcinogens in rasH2 mice. J Toxicol Sci 2003; 28: 371-83.
34. Ise K, Nakamura K, Nakao K et al. Targeted deletion of the H-ras gene decreases tumor formation in mouse skin carcinogenesis. Oncogene 2000; 19: 2951-6.
35. Manabe T, Aiba A, Yamada A et al. Regulation of long-term potentiation by H-Ras through NMDA receptor phosphorylation. J Neurosci 2000; 20: 2504-11.
36. Tsuda H, Asamoto M, Ochiya T et al. High susceptibility of transgenic rats carrying the human c-Ha-ras proto-oncogene to chemically-induced mammary carcinogenesis. Mutat Res 2001; 477: 173-82.
37. Leder A, Kuo A, Cardiff RD et al. v-Ha-ras transgene abrogates the initiation step in mouse skin tumorigenesis: Effects of phorbol esters and retinoic acid. Proc Natl Acad Sci USA 1990; 87: 9178-82.
38. Owens DM, Spalding JW, Tennant RW et al. Genetic alterations cooperate with v-Ha-ras to accelerate multistage carcinogenesis in TG.AC transgenic mouse skin. Cancer Res 1995; 55: 3171-8.
39. Thompson TA, Haag JD, Lindstrom MJ et al. Decreased susceptibility to NMU-induced mammary carcinogenesis in transgenic rats carrying multiple copies of a rat ras gene driven by the rat Harvey ras promoter. Oncogene 2002; 21: 2797-804.